Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS).

Rikke Søgaard Axel Cosmus Pyndt DiederichsenLars M RasmussenJess LambrechtsenFlemming H SteffensenLars FrostKenneth EgstrupGrazina UrbonavicieneMartin BuskJes S Lindholt

Published in: European heart journal (2022)

Comprehensive screening for CVD is overall cost effective at conventional thresholds for willingness to pay and also competitive to the cost effectiveness of common cancer screening programmes. The screening target group, however, needs to be settled.

Keyphrases

cardiovascular disease
type diabetes
clinical trial
young adults
papillary thyroid
cardiovascular events
placebo controlled